| UniProt ID | CCNB1_HUMAN | |
|---|---|---|
| UniProt AC | P14635 | |
| Protein Name | G2/mitotic-specific cyclin-B1 | |
| Gene Name | CCNB1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 433 | |
| Subcellular Localization | Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. | |
| Protein Description | Essential for the control of the cell cycle at the G2/M (mitosis) transition.. | |
| Protein Sequence | MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPILVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNSALVQDLAKAVAKV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Phosphorylation | ALRVTRNSKINAENK CCCCCCCCCCCHHHC | 31.46 | 17192257 | |
| 10 | Acetylation | LRVTRNSKINAENKA CCCCCCCCCCHHHCH | 43.45 | 25953088 | |
| 25 | Ubiquitination | KINMAGAKRVPTAPA HCCCCCCCCCCCCCC | 53.67 | - | |
| 25 | Acetylation | KINMAGAKRVPTAPA HCCCCCCCCCCCCCC | 53.67 | 25953088 | |
| 29 | Phosphorylation | AGAKRVPTAPAATSK CCCCCCCCCCCCCCC | 42.28 | 21406692 | |
| 34 | Phosphorylation | VPTAPAATSKPGLRP CCCCCCCCCCCCCCC | 39.11 | 21406692 | |
| 35 | Phosphorylation | PTAPAATSKPGLRPR CCCCCCCCCCCCCCC | 31.93 | 17192257 | |
| 36 | Ubiquitination | TAPAATSKPGLRPRT CCCCCCCCCCCCCCC | 38.46 | 32015554 | |
| 51 | Acetylation | ALGDIGNKVSEQLQA CHHHHHHHHHHHHHH | 41.76 | 26051181 | |
| 51 | Ubiquitination | ALGDIGNKVSEQLQA CHHHHHHHHHHHHHH | 41.76 | - | |
| 53 | Phosphorylation | GDIGNKVSEQLQAKM HHHHHHHHHHHHHHC | 22.64 | 30576142 | |
| 59 | Acetylation | VSEQLQAKMPMKKEA HHHHHHHHCCCCCCC | 30.49 | 25953088 | |
| 59 | Ubiquitination | VSEQLQAKMPMKKEA HHHHHHHHCCCCCCC | 30.49 | 33845483 | |
| 69 | Phosphorylation | MKKEAKPSATGKVID CCCCCCCCCCCCCCC | 37.44 | 17192257 | |
| 73 | Acetylation | AKPSATGKVIDKKLP CCCCCCCCCCCCCCC | 31.49 | 19608861 | |
| 73 | Ubiquitination | AKPSATGKVIDKKLP CCCCCCCCCCCCCCC | 31.49 | 33845483 | |
| 95 | Phosphorylation | MLVPVPVSEPVPEPE EEEEEECCCCCCCCC | 30.07 | - | |
| 111 | Sumoylation | EPEPEPVKEEKLSPE CCCCCCCCCCCCCCC | 71.51 | - | |
| 111 | Sumoylation | EPEPEPVKEEKLSPE CCCCCCCCCCCCCCC | 71.51 | - | |
| 116 | Phosphorylation | PVKEEKLSPEPILVD CCCCCCCCCCCEEEE | 37.98 | 20117088 | |
| 126 | Phosphorylation | PILVDTASPSPMETS CEEEECCCCCCCCCC | 28.18 | 20117088 | |
| 128 | Phosphorylation | LVDTASPSPMETSGC EEECCCCCCCCCCCC | 34.09 | 20117088 | |
| 133 | Phosphorylation | SPSPMETSGCAPAEE CCCCCCCCCCCCCCH | 20.69 | 20117088 | |
| 147 | Phosphorylation | EDLCQAFSDVILAVN HHHHHHHHHHEEEEC | 33.70 | 20117088 | |
| 175 | Phosphorylation | SEYVKDIYAYLRQLE HHHHHHHHHHHHHHH | 10.18 | 27642862 | |
| 177 | Phosphorylation | YVKDIYAYLRQLEEE HHHHHHHHHHHHHHH | 5.85 | 22817900 | |
| 190 | Ubiquitination | EEQAVRPKYLLGREV HHHCCCCHHHCCCCC | 37.66 | 21890473 | |
| 190 | Ubiquitination | EEQAVRPKYLLGREV HHHCCCCHHHCCCCC | 37.66 | 22817900 | |
| 190 | Ubiquitination | EEQAVRPKYLLGREV HHHCCCCHHHCCCCC | 37.66 | 21890473 | |
| 258 | Ubiquitination | AMFIASKYEEMYPPE HHHHHHCHHHHCCCC | 18.02 | 33845483 | |
| 262 | Phosphorylation | ASKYEEMYPPEIGDF HHCHHHHCCCCCCCE | 20.93 | 22210691 | |
| 273 | Phosphorylation | IGDFAFVTDNTYTKH CCCEEEEECCCCCHH | 19.65 | 22210691 | |
| 278 | Phosphorylation | FVTDNTYTKHQIRQM EEECCCCCHHHHHHH | 21.73 | 22210691 | |
| 279 | Ubiquitination | VTDNTYTKHQIRQME EECCCCCHHHHHHHH | 24.09 | 21906983 | |
| 279 | Ubiquitination | VTDNTYTKHQIRQME EECCCCCHHHHHHHH | 24.09 | - | |
| 310 | Phosphorylation | LHFLRRASKIGEVDV HHHHHHHHHCCCCCH | 24.01 | 23927012 | |
| 311 | Ubiquitination | HFLRRASKIGEVDVE HHHHHHHHCCCCCHH | 54.46 | 33845483 | |
| 311 | Ubiquitination | HFLRRASKIGEVDVE HHHHHHHHCCCCCHH | 54.46 | - | |
| 311 | Acetylation | HFLRRASKIGEVDVE HHHHHHHHCCCCCHH | 54.46 | 25953088 | |
| 321 | Phosphorylation | EVDVEQHTLAKYLME CCCHHHHHHHHHHHH | 28.27 | 17192257 | |
| 362 | Phosphorylation | ILDNGEWTPTLQHYL EHHCCCCCCCHHHHH | 11.33 | 25159151 | |
| 364 | Phosphorylation | DNGEWTPTLQHYLSY HCCCCCCCHHHHHHC | 31.51 | 25627689 | |
| 370 | Phosphorylation | PTLQHYLSYTEESLL CCHHHHHHCCHHHHH | 23.89 | 25627689 | |
| 372 | Phosphorylation | LQHYLSYTEESLLPV HHHHHHCCHHHHHHH | 29.87 | 25627689 | |
| 389 | Sulfoxidation | HLAKNVVMVNQGLTK HHHHCCEEECCCHHH | 1.72 | 21406390 | |
| 395 | Phosphorylation | VMVNQGLTKHMTVKN EEECCCHHHCCHHCC | 26.23 | - | |
| 396 | Ubiquitination | MVNQGLTKHMTVKNK EECCCHHHCCHHCCH | 36.10 | 29967540 | |
| 411 | Ubiquitination | YATSKHAKISTLPQL HCCCCCCCCCCHHHH | 36.59 | 29967540 | |
| 413 | Phosphorylation | TSKHAKISTLPQLNS CCCCCCCCCHHHHHH | 24.16 | 21712546 | |
| 428 | Ubiquitination | ALVQDLAKAVAKV-- HHHHHHHHHHHCC-- | 51.17 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 126 | S | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
| 126 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 126 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 126 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
| 126 | S | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
| 128 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 128 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 128 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 128 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
| 128 | S | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
| 133 | S | Phosphorylation | Kinase | PLK1 | P53350 | Uniprot |
| 133 | S | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
| 147 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:22529100 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BRCA1 | P38398 | PMID:23246971 |
| - | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:26387737 |
| - | K | Ubiquitination | E3 ubiquitin ligase | CDC20 | Q12834 | PMID:11285280 |
| - | K | Ubiquitination | E3 ubiquitin ligase | ZC3HC1 | Q86WB0 | PMID:16258267 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KLHL9 | Q9P2J3 | PMID:18075312 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KLHL10 | Q6JEL2 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KLHL11 | Q9NVR0 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KLHL12 | Q53G59 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KLHL13 | Q9P2N7 | PMID:18075312 |
| - | K | Ubiquitination | E3 ubiquitin ligase | ANAPC11 | Q9NYG5 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | RFPL4A | A6NLU0 | PMID:12525704 |
| - | K | Ubiquitination | E3 ubiquitin ligase | CCNB1IP1 | Q9NPC3 | PMID:12612082 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KLHL9#KLHL13 | Q9P2J3#Q9P2N7 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCNB1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-73, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-35; SER-69 ANDTHR-321, AND MASS SPECTROMETRY. | |
| "Active cyclin B1-Cdk1 first appears on centrosomes in prophase."; Jackman M., Lindon C., Nigg E.A., Pines J.; Nat. Cell Biol. 5:143-148(2003). Cited for: SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-126; SER-133 AND SER-147,AND MUTAGENESIS OF SER-133 AND SER-147. | |
| "Cooperative phosphorylation including the activity of polo-likekinase 1 regulates the subcellular localization of cyclin B1."; Yuan J., Eckerdt F., Bereiter-Hahn J., Kurunci-Csacsko E.,Kaufmann M., Strebhardt K.; Oncogene 21:8282-8292(2002). Cited for: SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-126; SER-128; SER-133 ANDSER-147, AND MUTAGENESIS OF SER-133. | |